Travere Therapeutics, Inc. (TVTX)
52.75
+3.34
(+6.76%)
USD |
NASDAQ |
Nov 04, 13:21
Travere Therapeutics Price : 52.75 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 46.52 | 49.68 | 44.73 | 49.41 | 9.080M |
| Nov 02, 2026 | 50.47 | 52.87 | 48.64 | 49.26 | 2.905M |
| Oct 30, 2026 | 50.01 | 52.66 | 49.71 | 50.39 | 1.141M |
| Oct 29, 2026 | 51.65 | 52.15 | 49.90 | 50.57 | 1.574M |
| Oct 28, 2026 | 50.20 | 50.91 | 49.52 | 50.84 | 1.573M |
| Oct 27, 2026 | 49.85 | 51.00 | 49.29 | 50.88 | 3.450M |
| Oct 26, 2026 | 50.52 | 51.32 | 49.24 | 49.97 | 3.342M |
| Oct 23, 2026 | 52.00 | 52.22 | 49.78 | 50.08 | 2.314M |
| Oct 22, 2026 | 52.34 | 53.12 | 51.25 | 52.43 | 1.774M |
| Oct 21, 2026 | 52.88 | 54.83 | 52.50 | 52.58 | 2.164M |
| Oct 20, 2026 | 50.43 | 52.70 | 50.40 | 52.30 | 2.058M |
| Oct 19, 2026 | 50.17 | 51.28 | 49.74 | 50.49 | 1.316M |
| Oct 16, 2026 | 52.56 | 52.56 | 49.46 | 49.60 | 1.828M |
| Oct 15, 2026 | 53.94 | 55.57 | 52.63 | 52.79 | 1.981M |
| Oct 14, 2026 | 51.61 | 53.94 | 51.53 | 53.27 | 2.061M |
| Oct 13, 2026 | 51.57 | 52.81 | 51.38 | 51.80 | 1.669M |
| Oct 12, 2026 | 51.74 | 53.35 | 51.74 | 52.02 | 1.424M |
| Oct 09, 2026 | 52.04 | 52.71 | 51.63 | 52.12 | 1.169M |
| Oct 08, 2026 | 53.44 | 53.44 | 51.45 | 52.04 | 1.647M |
| Oct 07, 2026 | 55.41 | 56.61 | 53.28 | 53.44 | 3.424M |
| Oct 06, 2026 | 57.86 | 58.77 | 55.16 | 55.98 | 3.108M |
| Oct 05, 2026 | 57.31 | 58.60 | 55.86 | 57.67 | 2.644M |
| Oct 02, 2026 | 57.21 | 57.53 | 56.34 | 56.93 | 1.722M |
| Oct 01, 2026 | 58.64 | 59.58 | 56.23 | 56.85 | 2.395M |
| Sep 30, 2026 | 60.35 | 60.47 | 58.83 | 58.88 | 1.561M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| TG Therapeutics, Inc. | 61.80 |
| BioMarin Pharmaceutical, Inc. | 56.61 |
| Vertex Pharmaceuticals, Inc. | 549.50 |
| Viridian Therapeutics, Inc. | 27.62 |
| RenovoRx, Inc. | 1.28 |
Price Related Metrics
| PS Ratio | 7.500 |
| PEG Ratio | -0.6004 |
| Price to Book Value | 223.47 |
| Price to Free Cash Flow | 56.96 |
| Earnings Yield | -3.15% |
| Market Cap | 4.968B |
| PEGY Ratio | -0.6004 |